Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 11, 2000

View Archived Issues

Grant awarded to Cel-Sci for herpes simplex vaccine development

Recent work reveals central role for SLPI protein in healing

A20 protein found to be key mediator of inflammatory processes

FeRx receives grant for magnetic targeting of radioactive microparticles

Cubist reaches milestone in Novartis collaboration

New therapeutic approach to AD licensed by Neurogenetics

Affymetrix forms new genomics company

Synaptic's alpha1-adrenoceptors and BPH patents licensed to R.W. Johnson

Starlix receives first European approval for type 2 diabetes

Connetics' phase III human relaxin trial for scleroderma falls short of primary endpoint

Micellar paclitaxel shows good safety and tolerability in phase I

Roche begins E.U. launch for Herceptin

Bayer investigates inhibition of hepatic glycogen phosphorylase as therapy for type 2 diabetes

Rationally designed HIV protease inhibitors with improved pharmacokinetic properties

Systemic recombinant human relaxin stimulates wound healing in rat models

Antiinflammatory activity of green tea extracts reported in Hot Springs

Role for rho kinase inhibitors in the management of ED

RSV subunit vaccine successfully proceeds through clinical trials

Vaccine for preventing UTIs in early clinical trials at MedImmune

Investigational treatment for AIDS-related CMV retinitis filed for approval with FDA

Recent patent covers new inhibitors of specific MMPs

Phosphoric acid derivatives useful for inflammatory disorders

Macrolide immunomodulators in the Abbott pipeline

Novel series of antimicrobial compounds identified by National Science Council

Roche discloses new NK1 antagonists and their therapeutic applications

Antitumor agents patented by Japanese researchers

Potentially safe and effective treatments for multiple sclerosis discovered at Active Biotech

Novel serotonergic agents from Sankyo and their use in CNS disorders

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...